BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
'Stranger Things' character guide: The nerds, the newcomers and the rest of the Season 5 cast - 2New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix
- 3Alice Wong, founder of the Disability Visibility Project, dies at 51
- 4One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- 5I was about to film a movie with Glen Powell when my hair started falling out in clumps. Alopecia has made me unrecognizable as an actor.
- Promising Speculation Bearings for Portfolio Development in 2024
- Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- The Extraordinary Excursion of Dental Embed Innovation
- Vote In favor of Your Favored Web-based Venture Stage
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- 5 Worldwide Road Food varieties You Should Attempt
- As nations push for more ambition at climate talks, chairman says they may get it
- Thousands of Walgreens nasal spray bottles recalled. See which ones.
- 6 Objections for an Ocean side Wedding
